A stability-indicating HPLC-PDA method for the determination of ferulic acid in chitosan-coated poly(lactide-co-glycolide) nanoparticles

被引:5
作者
de Lima, Isabela Angeli [1 ]
Khalil, Najeh Maissar [1 ]
Mainardes, Rubiana Mara [1 ]
机构
[1] Univ Estadual Ctr Oeste UNICENTRO, Dept Pharm, Lab Pharmaceut Nanotechnol, Rua Simeao Camargo Varela Sa 03, BR-85040080 Guarapuava, PR, Brazil
关键词
Nanoparticles; Ferulic acid/encapsulation efficiency; Ferulic acid/quantification; Stability; High performance liquid chromatography/validation; PLGA-poly(lactide-co-glycolide)/nanoparticles; Chitosan; DRUG-DELIVERY SYSTEMS; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; RAT PLASMA; PHENOLIC-COMPOUNDS; RHIZOMA-CHUANXIONG; CHLOROGENIC ACID; IDENTIFICATION; QUANTIFICATION; ENHANCEMENT;
D O I
10.1590/s2175-97902017000216138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development and validation of a simple and efficient method for the quantification of ferulic acid in poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles coated with chitosan (CS) by reverse phase high performance liquid chromatography coupled to photodiode array detection was described. For the chromatographic analysis, a reverse phase C-18 column was used, mobile phase consisting of acetonitrile and 0.5% acetic acid (37: 63, v/v), isocratically eluted at a flow rate of 1 mL/min. Drug determination was performed at 320 nm. The method was validated in terms of the selectivity, linearity, precision, accuracy, robustness, limits of detection and quantification. The method was linear in the range of 10 to 100 mu g/mL (r=0.999) and presented limit of detection and quantification of 102 ng/mL and 310 ng/mL, respectively. The method was precise (intra and inter-day) based on relative standard deviation values (less than 3.20%). The recovery was between 101.06 and 102.10%. Robustness was demonstrated considering change in mobile phase proportion. Specificity assay showed no interference from the components of nanoparticles or from the degradation products derived from acidic and oxidative conditions. The proposed method was suitable to be applied in determining the encapsulation efficiency of ferulic acid in PLGA-CS nanoparticles and can be employed as stability indicating one.
引用
收藏
页数:10
相关论文
共 50 条
[1]   Improved antioxidant capacity of quercetin and ferulic acid during in-vitro digestion through encapsulation within food-grade electrospun fibers [J].
Aceituno-Medina, Marysol ;
Mendoza, Sandra ;
Rodriguez, Beatriz A. ;
Maria Lagaron, Jose ;
Lopez-Rubio, Arnparo .
JOURNAL OF FUNCTIONAL FOODS, 2015, 12 :332-341
[2]   Content of phenolic acids and ferulic acid dehydrodimers in 17 rye (Secale cereale L.) varieties [J].
Andreasen, MF ;
Christensen, LP ;
Meyer, AS ;
Hansen, Å .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (07) :2837-2842
[3]   Analytical characterization of a ferulic acid/γ-cyclodextrin inclusion complex [J].
Anselmi, C ;
Centini, M ;
Ricci, M ;
Buonocore, A ;
Granata, P ;
Tsuno, T ;
Facino, RM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (04) :875-881
[4]  
AOAC, 2016, Appendix F: Guidelines for standard method performance requirements
[5]   Analytical methodologies for quantification of ferulic acid and its oligomers [J].
Barberousse, Helene ;
Roiseux, Olivier ;
Robert, Christelle ;
Paquot, Michel ;
Deroanne, Claude ;
Blecker, Christophe .
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2008, 88 (09) :1494-1511
[6]   Ferulic Acid-Loaded Lipid Nanostructures as Drug Delivery Systems for Alzheimer's Disease: Preparation, Characterization and Cytotoxicity Studies [J].
Bondi, M. L. ;
Montana, G. ;
Craparo, E. F. ;
Picone, P. ;
Capuano, G. ;
Di Carlo, M. ;
Giammona, G. .
CURRENT NANOSCIENCE, 2009, 5 (01) :26-32
[7]  
BRITISH PHARMACOPOEIA COMMISSION, 2011, BRIT PHARMACOPOEIA
[8]   FA-loaded lipid drug delivery systems: Preparation, characterization and biological studies [J].
Carbone, Claudia ;
Campisi, Agata ;
Musumeci, Teresa ;
Raciti, Giuseppina ;
Bonfanti, Roberta ;
Puglisi, Giovanni .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 52 :12-20
[9]  
Craparo EF, 2009, J DRUG TARGET, V17, P78, DOI [10.1080/10611860802455821, 10.1080/10611860802455821 ]
[10]   Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles [J].
das Neves, Jose ;
Sarmento, Bruno ;
Amiji, Mansoor M. ;
Bahia, Maria Fernanda .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 52 (02) :167-172